Use of the Sphenopalatine Ganglion Block to Treat Migraine Headaches in the Emergency Department

Aaron Morgan, Gennaro Romanello, Aaron Morgan, Gennaro Romanello

Abstract

Headaches are a common presenting complaint to the emergency department. Amongst the common non-life-threatening headaches, migraine headaches tend to be one of the more severe. Commonly, migraines are treated with the so-called "migraine cocktail." At our facility, this cocktail is usually IV fluids, metoclopramide, diphenhydramine, and ketorolac. The patient is then left in a quiet, dark room for two to three hours, then reassessed for symptom improvement or if more medications are required. Recently we have begun to employ the sphenopalatine ganglion (SPG) block as a rapid, and easy-to-administer alternative to the classic migraine cocktail. The SPG block can often provide sufficient improvement of symptoms within 15 minutes to allow the patient to be discharged. Patients are grateful to have such rapid pain relief, and the ED flow is improved with a door-to-discharge time that can be less than an hour. The following is a series of three recent cases where we have used the SPG block to treat migraines in our ED patients.

Keywords: common emergency department complaints; headache disorders; migraine; migraine treatment; nerve block; sphenopalantine ganglion block.

Conflict of interest statement

The authors have declared that no competing interests exist.

Copyright © 2022, Morgan et al.

References

    1. Headache Classification Committee of the International Headache Society (IHS) The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38:1–211.
    1. Role of greater occipital nerve block in headache disorders: a narrative review. Chowdhury D, Datta D, Mundra A. Neurol India. 2021;69:0–56.
    1. Treatment of acute migraine in the emergency department. Gupta S, Oosthuizen R, Pulfrey S. . Can Fam Physician. 2014;60:47–49.
    1. Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series. Lauritsen C, Mazuera S, Lipton RB, Ashina S. J Headache Pain. 2016;17:106.
    1. Propofol for treatment of acute migraine in the emergency department: a systematic review. Piatka C, Beckett RD. Acad Emerg Med. 2020;27:148–160.
    1. Non-pharmacological approaches for migraine. Puledda F, Shields K. Neurotherapeutics. 2018;15:336–345.
    1. Migraine treatment in the emergency department: alternatives to opioids and their effectiveness in relieving migraines and reducing treatment times. Dodson H, Bhula J, Eriksson S, Nguyen K. Cureus. 2018;10:0.
    1. Metoclopramide for acute migraine treatment in the emergency department: an effective alternative to opioids. Najjar M, Hall T, Estupinan B. Cureus. 2017;9:0.
    1. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Rabbie R, Derry S, Moore RA. Cochrane Database Syst Rev. 2013:0.
    1. Daith piercing: wonder treatment or untested fad? Bhandari P, Ranjit E, Sapra A, Davis D, Brenham C. Cureus. 2020;12:0.
    1. Sphenopalatine ganglion block and radiofrequency ablation: technical notes and efficacy. Tolba R, Weiss AL, Denis DJ. Ochsner J. 2019;19:32–37.
    1. Sphenopalatine ganglion: block, radiofrequency ablation and neurostimulation - a systematic review. Ho KW, Przkora R, Kumar S. J Headache Pain. 2017;18:118.
    1. Alexander CE, Dua A. Treasure Island, FL: StatPearls; Treasure Island, FL. Sphenopalatine Ganglion Block.
    1. Noninvasive sphenopalatine ganglion block for acute headache in the emergency department: a randomized placebo-controlled trial. Schaffer JT, Hunter BR, Ball KM, Weaver CS. Ann Emerg Med. 2015;65:503–510.
    1. Sphenopalatine ganglion block for the treatment of acute migraine headache. Binfalah M, Alghawi E, Shosha E, Alhilly A, Bakhiet M. Pain Res Treat. 2018;2018:2516953.
    1. The prevalence and impact of migraine and severe headache in the United States: Updated age, sex, and socioeconomic-specific estimates from government health surveys. Burch R, Rizzoli P, Loder E. Headache. 2021;61:60–68.
    1. Hospital burden of migraine in united states adults: a 15-year national inpatient sample analysis. Law HZ, Chung MH, Nissan G, Janis JE, Amirlak B. Plast Reconstr Surg Glob Open. 2020;8:0.
    1. A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with tx360(®) as acute treatment for chronic migraine. Cady R, Saper J, Dexter K, Manley HR. Headache. 2015;55:101–116.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit